Find Comparable ETFs for Invesco Biotechnology & Genome ETF
Invesco Biotechnology & Genome ETF
PBE - PCXFirst Trust NYSE Arca Biotechnology Index Fund
FBT - PCXThe First Trust NYSE Arca Biotechnology ETF includes a diversified selection of biotech stocks, similar to PBE's strategy of investing in biotech equities.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 87%
R-squared: 76%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 6
- FBT in PBE's comparables: Yes
- PBE in FBT's comparables: Yes
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- FBT Beta: 0.79 (Low)
- PBE Beta: 0.87 (Average)
- FBT 200-day Volatility: 14.96%
- PBE 200-day Volatility: 16.22%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- FBT Price vs 200-day MA: 104%
- PBE Price vs 200-day MA: 96%
Performance Comparison:
| Period | FBT | PBE |
|---|---|---|
| Year_1 | 9% | 12% |
| Year_3 | 0% | -3% |
| Year_5 | 4% | 5% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- FBT Dividend Yield: 0%
- PBE Dividend Yield: 0%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Invesco Pharmaceuticals ETF
PJP - PCX
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 80%
R-squared: 64%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 2
- PBE in PJP's comparables: Yes
- PJP in PBE's comparables: No
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- PBE Beta: 0.87 (Average)
- PJP Beta: 0.66 (Low)
- PBE 200-day Volatility: 16.22%
- PJP 200-day Volatility: 11.88%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- PBE Price vs 200-day MA: 96%
- PJP Price vs 200-day MA: 102%
Performance Comparison:
| Period | PBE | PJP |
|---|---|---|
| Year_1 | 12% | 10% |
| Year_3 | -3% | 3% |
| Year_5 | 5% | 9% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- PBE Dividend Yield: 0%
- PJP Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
ALPS Medical Breakthroughs ETF
SBIO - PCXThe Invesco Dynamic Biotechnology & Genome ETF targets biotechnology firms involved in drug development, making it a suitable peer to SBIO.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 76%
R-squared: 58%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 5
- PBE in SBIO's comparables: Yes
- SBIO in PBE's comparables: No
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- PBE Beta: 0.87 (Average)
- SBIO Beta: 0.92 (Average)
- PBE 200-day Volatility: 16.22%
- SBIO 200-day Volatility: 27.48%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- PBE Price vs 200-day MA: 96%
- SBIO Price vs 200-day MA: 86%
Performance Comparison:
| Period | PBE | SBIO |
|---|---|---|
| Year_1 | 12% | 14% |
| Year_3 | -3% | -7% |
| Year_5 | 5% | 0% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- PBE Dividend Yield: 0%
- SBIO Dividend Yield: -1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Loading comparable ETFs ...